Reuters logo
BRIEF-Verastem announces positive top-line data from the pivotal phase 3 Duo study
September 6, 2017 / 10:24 AM / 2 months ago

BRIEF-Verastem announces positive top-line data from the pivotal phase 3 Duo study

Sept 6 (Reuters) - Verastem Inc

* Verastem announces positive top-line data from the pivotal phase 3 Duo study in relapsed or refractory chronic lymphocytic leukemia and small lymphocytic lymphoma

* ‍Plans to share clinical data from pivotal phase 3 Duo study​ with FDA with goal of filing new drug application during first half of 2018 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below